Company / EPS (Diluted)
Cullinan Therapeutics, Inc. EPS (Diluted) History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$3.69
FY2023
5-year range
-$3.69 / $2.38
FY2021-FY2023
Trend
-255.0%
vs FY2022
Sector context
#158 of 204
Health Care
What the data says
EPS (Diluted) changed -255% YoY in FY2023, a notable deviation from the 2-year average annual change of -32%.
Based on SEC 10-K filings.
-3.69 in FY2023.
Declined from $-2.60 to $-3.69 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 204This company -$3.69 Sector average -$0.92
▼
-300.9% below sector average
Key checks
Key Insights
- In FY2023, eps (diluted) decreased 255.0% year-over-year.
- Ranks #158 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -$3.69 | -255.0% |
| FY2022 | $2.38 | +191.5% |
| FY2021 | -$2.60 | - |
| FY2020 | - | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026